Evidence map›Paper›PMID 25381374›Full record

ArticleThe Journal of infectious diseases2014

Heterogeneity in risk of pelvic inflammatory diseases after chlamydia infection: a population-based study in Manitoba, Canada.

Bethan Davies, Helen Ward, Stella Leung, Katy M E Turner, Geoff P Garnett, James F Blanchard, B Nancy Yu

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Bethan DaviesDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London.
Helen WardDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London.
Stella LeungCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba.
Katy M E TurnerSchool of Social and Community Medicine and School of Clinical Veterinary Science, University of Bristol, United Kingdom.
Geoff P GarnettBill and Melinda Gates Foundation, Seattle, Washington.
James F BlanchardCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba.
B Nancy YuCentre for Global Public Health, Department of Community Health Sciences, University of Manitoba Public Health Branch, Manitoba Health, Winnipeg, Canada.
Imperial College London · GBBill & Melinda Gates Foundation · USUniversity of Bristol · GB

Funding

CIHRDepartment of Health PDF-2009-02-55Medical Research Council G0902120Wellcome Trust 090285/Z/09/Z
6 · The paper itself

Abstract

backgroundThe association between chlamydia infection and pelvic inflammatory disease (PID) is a key parameter for models evaluating the impact of chlamydia control programs. We quantified this association using a retrospective population-based cohort.

methodsWe used administrative health data sets to construct a retrospective population-based cohort of women and girls aged 12-24 years who were resident in Manitoba, Canada, between 1992 and 1996. We performed survival analysis on a subcohort of individuals who were tested for chlamydia to estimate the risk of PID diagnosed in a primary care, outpatient, or inpatient setting after ≥ 1 positive chlamydia test.

resultsA total of 73 883 individuals contributed 625 621 person years of follow-up. Those with a diagnosis of chlamydia had an increased risk of PID over their reproductive lifetime compared with those who tested negative (adjusted hazard ratio [AHR], 1.55; 95% confidence interval [CI], 1.43-1.70). This risk increased with each subsequent infection: the AHR was 1.17 for first reinfection (95% CI, 1.06-1.30) and 1.35 for the second (95% CI, 1.04-1.75). The increased risk of PID from reinfection was highest in younger individuals (AHR, 4.55 (95% CI, 3.59-5.78) in individuals aged 12-15 years at the time of their second reinfection, compared with individuals older than 30 years).

conclusionsThere is heterogeneity in the risk of PID after a chlamydia infection. Describing the progression to PID in mathematical models as an average rate may be an oversimplification; more accurate estimates of the cost-effectiveness of screening may be obtained by using an individual-based measure of risk. Health inequalities may be reduced by targeting health promotion interventions at sexually active girls younger than 16 years and those with a history of chlamydia.

Indexed as

Chlamydia trachomatisAdolescentAdultAge DistributionAge FactorsChildChlamydia InfectionsFemaleHumansKaplan-Meier EstimateManitobaPelvic Inflammatory DiseaseProportional Hazards ModelsRetrospective StudiesRiskYoung AdultChlamydia trachomatiscohort studycost effectivenessepidemiologymathematical modelspelvic inflammatory diseaseretrospective study

Identifiers

PMID25381374
PMCPMC4231643
OpenAlexW2145864273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.